Item request has been placed!

Item request cannot be made.

Processing Request

Search Results

Display Settings

Results per page: 10

Sort By: Relevance

Your Filters

Subject : 03 medical and health sciences Filter by : Author

Item request has been placed!

Item request cannot be made.

Processing Request

Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease

Authors : Niels Jongs; Douwe Postmus; Ricardo Correa-Rotter ...

Subjects: Male; medicine.medical_specialty; Disease

Source: Circulation, 143(5), 438-448. LIPPINCOTT WILLIAMS & WILKINS

Read Online Read More Add to Saved list

Effects of exenatide and open-label SGLT2 inhibitor treatment, given in parallel or sequentially, on mortality and cardiovascular and renal outcomes in type 2 diabetes: insights from the EXSCEL trial

Authors : Robert C. Penland; Marcus Thuresson; Robert J. Mentz ...

Subjects: Male; eGFR slope; lcsh:Diseases of the circulatory (Cardiovascular) system

Source: Cardiovascular Diabetology, Vol 18, Iss 1, Pp 1-12 (2019)Cardiovascular DiabetologyCardiovascular Diabetology, 18(1):138. BioMed Central Ltd.

Read Online Read More Add to Saved list

A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy

Authors : Ricardo Correa-Rotter; Bergur V. Stefánsson; David C. Wheeler ...

Subjects: 0301 basic medicine; sodium-glucose cotransporter inhibitor; medicine.medical_specialty

Source: Kidney International, 100(1), 215-224. ELSEVIER SCIENCE INCDAPA-CKD Trial Committees and Investigators 2021, ' A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of

Read Online Read More Add to Saved list

Effects of the sodium-glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b-4 chronic kidney disease

Authors : Claire C J Dekkers; David C. Wheeler; C. David Sjöström ...

Subjects: Male; Blood Pressure; Type 2 diabetes

Source: Nephrology Dialysis Transplantation, 33(11), 2005-2011. Oxford University PressNephrology Dialysis Transplantation

Read Online Read More Add to Saved list

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Authors : Investigators; Niels Jongs; Raisa Kurlyandskaya ...

Subjects: Relative risk reduction; Adult; Male

Source: European Heart JournalDAPA-CKD Trial Committees and Investigators 2021, ' Effects of dapagliflozin on mortality in patients with chronic kidney disease : a pre-specified analysis from the

Read Online Read More Add to Saved list

Correction of anemia by dapagliflozin in patients with type 2 diabetes

Authors : Bergur V. Stefánsson; Ricardo Correa-Rotter; David C. Wheeler ...

Subjects: CHRONIC KIDNEY-DISEASE; medicine.medical_specialty; Anemia

Source: JOURNAL OF DIABETES AND ITS COMPLICATIONS, 34(12):107729. ELSEVIER SCIENCE INC

Read Online Read More Add to Saved list

A Randomized Controlled Trial of Dapagliflozin Plus Once-Weekly Exenatide Versus Placebo in Individuals with Obesity and Without Diabetes: Metabolic Effects and Markers Associated with Bodyweight Loss

Authors : Maria J. Pereira; Per Lundkvist; Prasad G. Kamble

Subjects: 0301 basic medicine; Weight loss; medicine.medical_specialty

Source: Diabetes Therapy

Read Online Read More Add to Saved list

Efficacy and safety of dapagliflozin in Asian patients: A pooled analysis

Authors : Linong Ji; Wenying Yang; Zhiguang Zhou

Subjects: Creatinine; medicine.medical_specialty; education.field_of_study

Source: Journal of Diabetes. 9:787-799

Read Online Read More Add to Saved list

Efficacy and Safety Over 2 Years of Exenatide Plus Dapagliflozin in the DURATION-8 Study: A Multicenter, Double-Blind, Phase 3, Randomized Controlled Trial

Authors : Juan P. Frias; Serge Jabbour; Azazuddin Ahmed

Subjects: Adult; Blood Glucose; Male

Source: Diabetes Care

Read Online Read More Add to Saved list

6-LB: Effect of Open-Label SGLT2 Inhibitor Treatment When Combined with Exenatide on Cardiovascular and Renal Outcomes in EXSCEL

Authors : David W. Boulton; Marcus Thuresson; James A. Ruggles

Subjects: 0301 basic medicine; medicine.medical_specialty; business.industry

Source: Diabetes. 68

Read Online Read More Add to Saved list